New Cell Therapy Using Bone Marrow-Derived Stem Cells/Endothelial Progenitor Cells to Accelerate Neovascularization in Healing of Experimental Ulcerative Colitis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|16|1643-1651

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.16, 2011-06, pp. : 1643-1651

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stromal Cell-Derived Factor-1 Enhances Wound Healing through Recruiting Bone Marrow-Derived Mesenchymal Stem Cells to the Wound Area and Promoting Neovascularization

By  

Cells Tissues Organs, Vol. 197, Iss. 2, 2012-11 ,pp. : 103-113

Karger

Access to resources Recommend Favorite

Stem Cell Therapy for Arterial Restenosis: Potential Parameters Contributing to the Success of Bone Marrow-Derived Mesenchymal Stromal Cells

By Forte Amalia   Rinaldi Barbara   Sodano Loredana   Berrino Liberato   Rossi Francesco   Finicelli Mauro   Grossi Mario   Cobellis Gilda   Botti Chiara   Feo Marisa   Santè Pasquale   Galderisi Umberto   Cipollaro Marilena  

Cardiovascular Drugs and Therapy, Vol. 26, Iss. 1, 2012-02 ,pp. : 9-21

Springer Publishing Company

Access to resources Recommend Favorite

Bone Marrow-Derived Endothelial Progenitor Cells: A Promising Therapeutic Alternative for Corneal Endothelial Dysfunction

By  

Cells Tissues Organs, Vol. 193, Iss. 4, 2010-10 ,pp. : 253-263

Karger

Access to resources Recommend Favorite

Acute Hepatic Failure-Derived Bone Marrow Mesenchymal Stem Cells Express Hepatic Progenitor Cell Genes

By  

Cells Tissues Organs, Vol. 194, Iss. 5, 2011-02 ,pp. : 371-381

Karger

Access to resources Recommend Favorite

Mechanistic Insights into Arterial Repair with Mesenchymal Stromal Cells: Editorial to: “Stem Cell Therapy for Arterial Restenosis: Potential Parameters Contributing to the Success of Bone Marrow-Derived Mesenchymal Stromal Cells“ by A. Forte et al.

By Psaltis Peter  

Cardiovascular Drugs and Therapy, Vol. 26, Iss. 1, 2012-02 ,pp. : 1-3

Springer Publishing Company

Access to resources Recommend Favorite